Transfersomes and Transfersomal Gels as Carriers for Dermal Delivery of Mitragynine from Mitragyna speciosa Extract: Skin Absorption, Anti-Inflammation, and Safety Assessment

Abstract This study aimed to investigate the transfersomes and transfersomal gels of Mitragyna speciosa ethanolic extract (MSE) as carriers for the dermal delivery of mitragynine with prospects for localized delivery. Fifteen transfersome formulations of MSE (MSE-TFs) were developed using three different surfactants as edge activators (EAs): polysorbate 80 (P80), Span 80 (S80), and sodium cholate (SC), with varying phospholipid-to-edge activator (PC/EA) ratios and MSE loadings. Effects of surfactant types and ratios on the physicochemical properties and cytotoxicity of the MSE-TFs were analyzed. All MSE-TFs demonstrated satisfactory appearance and physicochemical properties. HaCaT cell viability varied among the formulations and test concentrations, generally decreasing at elevated MSE-TF concentrations. MSE-TFs containing phospholipids and P80 at a 9:1 ratio exhibited favorable skin permeation and deposition, alongside anti-inflammatory activity, demonstrated by the inhibition of NO and PGE2 production in RAW264.7 cells. Molecular docking further supported these findings by suggesting a potential interaction between mitragynine and the COX-2 active site, providing mechanistic insights into its anti-inflammatory activity. Mitragynine flux increased with increasing MSE loading, and the incorporation of diethylene glycol monoethyl ether markedly enhanced skin deposition of MSE-TFG (i.e., MSE-TF in a gel base). In vivo studies have demonstrated greater skin localization of mitragynine compared to systemic exposure without causing detectable skin irritation. Furthermore, mitragynine demonstrated enhanced chemical stability in MSE-TFGs compared to that in the crude extract under the evaluated storage conditions. These findings demonstrate the feasibility of using MSE-TFs and MSE-TFGs for the stabilized and localized dermal delivery of mitragynine, supporting further investigation of their potential for topical anti-inflammatory applications.

Authors

Institutions

Publication Details

Journal
ACS Omega
Published
2026-11-13
DOI
https://doi.org/10.1021/acsomega.6c09431
Primary Topic
Advancements in Transdermal Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Transfersomes and Transfersomal Gels as Carriers for Dermal Delivery of Mitragynine from Mitragyna speciosa Extract: Skin Absorption, Anti-Inflammation, and Safety Assessment

Jintana Junlatat, Napaphak Jaipakdee, Ekapol Limpongsa, Tarapong Srisongkram et al.
2 links
ACS Omega
Advancements in Transdermal Drug Delivery
article

Transfersomes and Transfersomal Gels as Carriers for Dermal Delivery of Mitragynine from Mitragyna speciosa Extract: Skin Absorption, Anti-Inflammation, and Safety Assessment

Jintana Junlatat, Napaphak Jaipakdee, Ekapol Limpongsa, Tarapong Srisongkram, Huỳnh Anh Duy, Sarunya Tuntiyasawasdikul
article en

Abstract

Abstract This study aimed to investigate the transfersomes and transfersomal gels of Mitragyna speciosa ethanolic extract (MSE) as carriers for the dermal delivery of mitragynine with prospects for localized delivery. Fifteen transfersome formulations of MSE (MSE-TFs) were developed using three different surfactants as edge activators (EAs): polysorbate 80 (P80), Span 80 (S80), and sodium cholate (SC), with varying phospholipid-to-edge activator (PC/EA) ratios and MSE loadings. Effects of surfactant types and ratios on the physicochemical properties and cytotoxicity of the MSE-TFs were analyzed. All MSE-TFs demonstrated satisfactory appearance and physicochemical properties. HaCaT cell viability varied among the formulations and test concentrations, generally decreasing at elevated MSE-TF concentrations. MSE-TFs containing phospholipids and P80 at a 9:1 ratio exhibited favorable skin permeation and deposition, alongside anti-inflammatory activity, demonstrated by the inhibition of NO and PGE2 production in RAW264.7 cells. Molecular docking further supported these findings by suggesting a potential interaction between mitragynine and the COX-2 active site, providing mechanistic insights into its anti-inflammatory activity. Mitragynine flux increased with increasing MSE loading, and the incorporation of diethylene glycol monoethyl ether markedly enhanced skin deposition of MSE-TFG (i.e., MSE-TF in a gel base). In vivo studies have demonstrated greater skin localization of mitragynine compared to systemic exposure without causing detectable skin irritation. Furthermore, mitragynine demonstrated enhanced chemical stability in MSE-TFGs compared to that in the crude extract under the evaluated storage conditions. These findings demonstrate the feasibility of using MSE-TFs and MSE-TFGs for the stabilized and localized dermal delivery of mitragynine, supporting further investigation of their potential for topical anti-inflammatory applications.

ACS Omega
Can Tho University (VN), Khon Kaen University (TH), Ubon Ratchathani Rajabhat University (TH), Rangsit University (TH)
Khon Kaen University
Good health and well-being
Advancements in Transdermal Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon